These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 24476081

  • 1. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
    Takahashi H, Komaba H, Takahashi Y, Sawada K, Tatsumi R, Kanai G, Suzuki H, Kakuta T, Fukagawa M.
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy.
    Liao SC, Moi SH, Chou FF, Yang CH, Chen JB.
    Biomed Res Int; 2016 Apr; 2016():6453803. PubMed ID: 27999806
    [Abstract] [Full Text] [Related]

  • 4. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M.
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [Abstract] [Full Text] [Related]

  • 5. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
    Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB.
    Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
    [Abstract] [Full Text] [Related]

  • 6. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism.
    Koizumi M, Komaba H, Nakanishi S, Fujimori A, Fukagawa M.
    Nephrol Dial Transplant; 2012 Feb; 27(2):784-90. PubMed ID: 21730210
    [Abstract] [Full Text] [Related]

  • 7. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 8. Changes in serum FGF23 and Klotho levels and calcification scores of the abdominal aorta after parathyroidectomy for secondary hyperparathyroidism.
    Chou FF, Chen JB, Huang SC, Chan YC, Chi SY, Chen WT.
    Am J Surg; 2019 Sep; 218(3):609-612. PubMed ID: 30594298
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 10. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.
    Lin HC, Chen CL, Lin HS, Chou KJ, Fang HC, Liu SI, Hsu CY, Huang WC, Huang CW, Huang CK, Chang TY, Chang YT, Lee PT.
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):508-15. PubMed ID: 24102421
    [Abstract] [Full Text] [Related]

  • 11. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    Parfrey PS, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Dehmel B, Trotman ML, Modafferi DM, Goodman WG.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
    [Abstract] [Full Text] [Related]

  • 12. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH, Liou HH, Wu MS, Lin CY, Huang CC.
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N.
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
    Zitt E, Rix M, Ureña Torres P, Fouque D, Jacobson SH, Pétavy F, Dehmel B, Ryba M.
    Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
    [Abstract] [Full Text] [Related]

  • 16. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, Patiu IM, Gherman-Căprioară M.
    Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A, Fahmi M, ElSayed M, Aboud O, Asim M.
    Transplant Proc; 2004 Nov; 36(6):1815-7. PubMed ID: 15350484
    [Abstract] [Full Text] [Related]

  • 18. The association of the Klotho polymorphism rs9536314 with parameters of calcium-phosphate metabolism in patients on long-term hemodialysis.
    Marchelek-Myśliwiec M, Różański J, Ogrodowczyk A, Dutkiewicz G, Dołęgowska B, Sałata D, Budkowska M, Safranow K, Stępniewska J, Wiśniewska M, Ciechanowski K.
    Ren Fail; 2016 Jun; 38(5):776-80. PubMed ID: 27055909
    [Abstract] [Full Text] [Related]

  • 19. Serum fetuin-A levels increased following parathyroidectomy in uremic hyperparathyroidism.
    Wang CC, Hsu YJ, Wu CC, Yang SS, Chen GS, Lin SH, Chu P.
    Clin Nephrol; 2012 Feb; 77(2):89-96. PubMed ID: 22257538
    [Abstract] [Full Text] [Related]

  • 20. Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism.
    Kuczera P, Adamczak M, Wiecek A.
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):607-12. PubMed ID: 24111496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.